Striatal Dopamine D(2/3) Receptor Availability in Treatment Resistant Depression

Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD. However, the role of dopaminergic signaling through measurement of striatal dopamine D(2/3) rece...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: de Kwaasteniet, Bart P., Pinto, Chedwa, Ruhé, Eric H. G., van Wingen, Guido A., Booij, Jan, Denys, Damiaan
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239080/
https://ncbi.nlm.nih.gov/pubmed/25411966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113612
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars